A detailed history of Legato Capital Management LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Legato Capital Management LLC holds 24,853 shares of VRNA stock, worth $1.68 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
24,853
Previous 10,670 132.92%
Holding current value
$1.68 Million
Previous $306,000 277.12%
% of portfolio
0.16%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$28.71 - $47.02 $407,193 - $666,884
14,183 Added 132.92%
24,853 $1.15 Million
Q2 2024

Jul 26, 2024

BUY
$11.48 - $17.02 $122,491 - $181,603
10,670 New
10,670 $154,000
Q4 2023

Jan 16, 2024

BUY
$11.94 - $20.47 $60,082 - $103,005
5,032 Added 26.08%
24,329 $483,000
Q2 2023

Aug 17, 2023

BUY
$19.41 - $23.43 $374,554 - $452,128
19,297 New
19,297 $407,000

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $4.11B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.